Enovis (ENOV) FCF Payout Ratio (2012 - 2013)
Enovis' (ENOV) quarterly FCF Payout Ratio came in at 0.11 in Q3 2013, down 63.61% year-on-year from 0.31 in Q3 2012, and down 24.15% on a QoQ basis from 0.15 in Q4 2012.
Enovis (ENOV) FCF Payout Ratio (2012 - 2013) Analysis & Trends
Enovis (ENOV) has 2 years of FCF Payout Ratio data on file, last reported at 0.11 in Q3 2013.
- On a quarterly basis, FCF Payout Ratio fell 63.61% year-over-year to 0.11 in Q3 2013; TTM through Dec 2013 was 0.13, a 59.45% decrease from a year earlier, with the FY2019 full-year figure at 16.86, changed N/A from the prior year.
- FCF Payout Ratio for Q3 2013 stood at 0.11, down from 0.15 in the prior quarter.
- Over the last five years, FCF Payout Ratio for ENOV reached as high as 0.31 in Q3 2012 and fell as low as 0.02 in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.20 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.81 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.44 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.14 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 27, 2013 | 0.11 |
| Dec 31, 2012 | 0.15 |
| Sep 28, 2012 | 0.31 |
| Jun 29, 2012 | -0.02 |
| Mar 30, 2012 | -0.02 |